BioNTech says ‘no evidence’ its jabs need adapting for variants
German firm BioNTech said Monday that the COVID-19 vaccine it developed with Pfizer does not require any modifications at the moment to protect against variants of the virus.
by ·
German firm BioNTech said Monday that the COVID-19 vaccine it developed with Pfizer does not require any modifications at the moment to protect against variants of the virus.
by · Published April 28, 2021
by · Published May 20, 2021
by · Published June 2, 2021